Manuel Osorio

Title: Innovations of Manuel Osorio

Introduction

Manuel Osorio is an accomplished inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and plasmid constructs. With a total of 3 patents, his work has the potential to impact public health positively.

Latest Patents

One of his latest patents involves the generation of a plasmid construct for the expression of aF1-V fusion protein. This plasmid is designed with the F1-V fusion protein coding sequence operably linked to the htrA promoter, fused in-frame to the HlyA secretion signal sequence. Additionally, he has developed a serovar Typhi strain Ty21a containing the F1-V fusion protein expression plasmid, which is intended for use as an oral vaccine against plague. Another notable invention relates to intracellularly induced bacterial DNA promoters and vaccines against anthrax.

Career Highlights

Manuel Osorio works at the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to engage in cutting-edge research that addresses critical health challenges.

Collaborations

He has collaborated with notable colleagues, including Dennis J. Kopecko and Siba Bhattacharyya, to advance his research and innovations in the field.

Conclusion

Manuel Osorio's contributions to biotechnology and vaccine development demonstrate his commitment to improving public health through innovative solutions. His patents reflect a dedication to scientific advancement and collaboration in research.